EGFR and polycystic ovary syndrome: The results of KEGG functional enrichment analysis revealed that the active components of CFDT affected obese PCOS mainly through the PI3K-AKT, TNF, HIF-1, and IL-17 signaling pathways, and EGFR tyrosine kinase inhibitor resistance (the bubble chart of the top 20 is exhibited in Figure 7B).